Experimental photodynamic therapy for liver cancer cell-implanted nude mice by an indole-3-acetic acid and intense pulsed light combination

Biological and Pharmaceutical Bulletin

Volumn 32, Issue 9, 2009, Pages 1609-1613

  Park, Kyoung Chan ^a   Kim, So Young ^b   Kim, Dong Seok ^b  

^a Seoul National University College of Medicine   (South Korea)

^b Chung Ang University   (South Korea)

Author keywords

Apoptosis; Hepatoma; Horseradish peroxidase; Indole 3 acetic acid; Intense pulsed light

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; 8 HYDROXYDEOXYGUANOSINE; CASPASE 3; CYCLINE; INDOLEACETIC ACID; PROTEIN P53;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; FEASIBILITY STUDY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LIVER CANCER; MALE; MOUSE; NICK END LABELING; NONHUMAN; PHOTODYNAMIC THERAPY; THERAPY EFFECT;

ANIMALS; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; INDOLEACETIC ACIDS; LIGHT; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; PHOTOCHEMOTHERAPY; ULTRAVIOLET RAYS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 69949141604     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.32.1609     Document Type: Article

References (21)

1. Goldsmith M. H., Proc. Natl. Acad. Sci. U.S.A., 90, 11442-11445 (1993).
2. Folkes L. K., Wardman P., Biochem. Pharmacol., 61, 129-136 (2001).
3. Gazaryan I. G., Lagrimini L. M., Ashby G. A., Thorneley R. N., Biochem. J., 313 (Pt. 3), 841-847 (1996).
4. Kim D. S., Jeon S. E., Park K. C., Cell. Signal., 16, 81-88 (2004).
5. Candeias L. P., Folkes L. K., Porssa M., Parrick J., Wardman P., Free Radic. Res., 23, 403-418 (1995).
6. Kim D. S., Jeon S. E., Jeong Y. M., Kim S. Y., Kwon S. B., Park K. C., FEBS Lett., 580, 1439-1446 (2006).
7. Folkes L. K., Wardman P., Cancer Res., 63, 776-779 (2003).
8. Kim D. S., Kim S. Y., Jeong Y. M., Jeon S. E., Kim M. K., Kwon S. B., Na J. I., Park K. C., Biol. Pharm. Bull., 29, 2404-2409 (2006).
9. Dougherty T. J., Gomer C. J., Henderson B. W., Jori G., Kessel D., Korbelik M., Moan J., Peng Q., J. Natl. Cancer Inst., 90, 889-905 (1998).
10. Raulin C., Greve B., Grema H., Lasers Surg. Med., 32, 78-87 (2003).
11. Valkonen M., Kuusi T., J. Lipid Res., 38, 823-833 (1997).
12. McCune L. M., Johns T., J. Ethnopharmacol., 82, 197-205 (2002).
13. Wardman P., Curr. Pharm. Des., 8, 1363-1374 (2002).
14. Tafazoli S., O'Brien P. J., Chem. Res. Toxicol., 17, 1350-1355 (2004).
15. Kawano T., Kawano N., Hosoya H., Lapeyrie F., Biochem. Biophys. Res. Commun., 288, 546-551 (2001).
16. Pires de Melo M., Curi T. C., Miyasaka C. K., Palanch A. C., Curi R., Gen. Pharmacol., 31, 573-578 (1998).
17. Folkes L. K., Dennis M. F., Stratford M. R., Candeias L. P., Wardman P., Biochem. Pharmacol., 57, 375-382 (1999).
18. Folkes L. K., Candeias L. P., Wardman P., Int. J. Radiat. Oncol. Biol. Phys., 42, 917-920 (1998).
19. Martinez E., Artigas F., Sunol C., Tusell J. M., Gelpi E., Clin. Chem., 29, 1354-1357 (1983).
20. Diengott D., Mirsky I. A., Proc. Soc. Exp. Biol. Med., 93, 109-110 (1956).
21. Rysanek K., Vitek V., Experientia, 15, 217-218 (1959).